Industry
Sponsorship
For sponsorship opportunities, please contact:
ISICEM Manager Véronique De Vlaeminck
For opportunities in our daily Newsletter please see the MediaPack here
and contact Paul Singh directly at contact@captivatemedia.co.uk
We thank the following companies for sponsoring the 42nd International Symposium on Intensive Care & Emergency Medicine.


AOP Health
The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”). The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions operating from its headquarters in Vienna.
Contact
Nicole Filacchione mailSatellite Meeting(s)

Cardiovascular Management in Sepsis: Optimizing Vascular and Cardiac Performance
Tuesday March 21 (12:30- 13:30 CET) Copper Hall
Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen.
Contact
Ann Van Houtven mailSatellite Meeting(s)

IDENTIFYING AND TREATING THE SEPSIS PATIENT IN ED
Tuesday March 21 (12:30- 13:30 CET) 100 Hall
HANDLING MULTI-ORGAN FAILURE IN THE CRITICALLY ILL
Wednesday March 22 (12:30- 13:30 CET) The Arc Room
CONTROVERSIES IN NUTRITION SUPPORT AND IV FLUIDS IN THE ICU
Thursday March 23 (12:30- 13:30 CET) 100 Hall
CSL Behring
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
Contact
Alexander Molitor mailSatellite Meeting(s)

Implementation of Patient Blood Management for improved patient outcomes
Wednesday March 22 (12:30- 13:30 CET) Copper Hall
CytoSorbents Europe GmbH
CytoSorbents is a critical care focused immunotherapy company using blood purification to modulate systemic inflammation - with the goal of preventing or treating multi-organ failure in life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and adsorption.
Contact
mailSatellite Meeting(s)

Hemoadsorption with CytoSorb® - New evidence from current studies
Thursday March 23 (12:30- 13:30 CET) Copper Hall
Hamilton Medical AG
Hamilton Medical is committed to helping medical teams deliver the best respiratory care - to anyone, anywhere. With Intelligent Ventilation technologies that are safe, easy to use, and lung protective, we strive to lessen the load for the frontline heroes of critical care.
Contact
mailSatellite Meeting(s)

My bedside tools for individualized mechanical ventilation.
Wednesday March 22 (12:30- 13:30 CET) 100 Hall

Alexion Pharma
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases. As a leader in rare diseases for 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Beckman Coulter
Contact
mailSatellite Meeting(s)

Detecting Sepsis with the First Blood Test: Role for MDW Parameter in Sepsis Diagnosis
Tuesday March 21 (17:00- 18:00 CET) 100 Hall
Biotest AG
Biotest is a provider of plasma proteins and biological drugs. Biotest has specialized primarily in the areas of clinical immunology, hematology and intensive care medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma. These are used for diseases of the immune and hematopoietic systems.

CARL.
CARL. The first mobile concept to control extracorporeal cardiopulmonary resuscitation (ECPR) after cardiac arrest. The CARL Therapy, empowered by the unique CARL Technology, focuses on limiting reperfusion injury from the beginning, which enables emergency teams along with the CARL Academy to strengthen the chain of survival. CARL. Vision. Neurologically intact survival.
Contact
mail
Edwards Lifesciences
Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
Contact
contact usSatellite Meeting(s)

Treating Haemodynamic instability – new evidence!
Tuesday March 21 (12:30- 13:30 CET) Silver Hall
Fisher & Paykel Healthcare
Fisher & Paykel Healthcare has been specialized in respiratory humidification for more than 40 years. Based in New Zealand, our company develops and produces innovative solutions for hospital care and homecare: heated humidifiers, single use patient kits and interfaces for respiratory therapies, invasive ventilation to oxygen therapy. OptiflowTM is one of our last innovations, extending the traditional boundaries of oxygen therapy.
Contact
mail
Fresenius Kabi
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company’s products and services are used to help care for critically and chronically ill patients. Its product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies, and clinical nutrition products as well as related devices.
Contact
Ann-Carin Friz mailSatellite Meeting(s)

Enhancing Recovery in Critical Illness with Medical Nutrition Therapy - New Insights
Wednesday March 22 (12:30- 13:30 CET) Panoramic Hall
Fresenius Medical Care
Fresenius Medical Care is a leading healthcare company with special focus on renal care. Besides a wide range of products for the treatment of acute kidney injury (AKI), the company also offers specialized extracorporeal blood treatment therapies for various critical diseases, including heart and lung failure, sepsis and severe metabolic disorders.
Contact
mailSatellite Meeting(s)

Practical knowledge in citrateanticoagulated CKRT
Thursday March 23 (12:30- 13:30 CET) Silver Hall
ADODB.Field
error '800a0bcd'
Either BOF or EOF is True, or the current record has been deleted. Requested operation requires a current record.
/19/Industry_new.asp, line 1732